Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Eli Lilly and Company (LLY)

Eli Lilly and Company (LLY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 145,909,504
  • Shares Outstanding, K 956,470
  • Annual Sales, $ 22,320 M
  • Annual Income, $ 8,318 M
  • 60-Month Beta 0.21
  • Price/Sales 6.46
  • Price/Cash Flow 21.27
  • Price/Book 33.72

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate 1.78
  • Number of Estimates 3
  • High Estimate 1.87
  • Low Estimate 1.66
  • Prior Year 1.48
  • Growth Rate Est. (year over year) +20.27%

Price Performance

See More
Period Period Low Period High Performance
1-Month
148.74 +1.45%
on 07/31/20
167.71 -10.03%
on 07/20/20
-11.19 (-6.90%)
since 07/13/20
3-Month
139.68 +8.03%
on 06/15/20
170.75 -11.63%
on 07/09/20
-7.04 (-4.46%)
since 05/13/20
52-Week
101.36 +48.87%
on 10/23/19
170.75 -11.63%
on 07/09/20
+35.19 (+30.41%)
since 08/13/19

Most Recent Stories

More News
Look for Shares of Eli Lilly & Co to Potentially Rebound after Yesterday's 1.34% Sell Off

Eli Lilly & Co (NYSE:LLY) traded in a range yesterday that spanned from a low of $149.79 to a high of $151.69. Yesterday, the shares fell 1.3%, which took the trading range below the 3-day low of $150.20...

LLY : 150.54 (-1.32%)
Eli Lilly & Co Set to Possibly Rebound After Yesterday's Selloff of 1.34%

Eli Lilly & Co (NYSE:LLY) traded in a range yesterday that spanned from a low of $149.79 to a high of $151.69. Yesterday, the shares fell 1.3%, which took the trading range below the 3-day low of $150.20...

LLY : 150.54 (-1.32%)
Eli Lilly & Co (LLY) Approaches New Downside Target of $149.54

Eli Lilly & Co (NYSE:LLY) has opened bearishly below the pivot of $152.11 today and has reached the first level of support at $151.04. Should the shares continue to fall, the support pivots of $149.54...

LLY : 150.54 (-1.32%)
Wireless Devices Offer New Ways to Diagnose Patients Remotely

, /PRNewswire/ -- With over 5 million people confirmed to be infected with the virus in the United States alone, the pandemic has made it vital for hospitals to diagnose patients early and monitor their...

GSK : 41.23 (-2.21%)
NMRD : 5.67 (+0.71%)
BNTX : 70.95 (+2.66%)
LLY : 150.54 (-1.32%)
CYDY : 4.2500 (-4.71%)
US Biosimilars Market Size to Reach $22,996 Million by 2027; Recent Scientific Discoveries Have Indicated Signs of a Promising Future, says Fortune Business Insights(TM)

The US Biosimilars Market size is projected to reach USD 22,966 million by the end of 2027. The presence of several large scale companies that are engaged in the research and development of efficient biosimilars...

ABBV : 94.92 (-0.62%)
AMGN : 240.01 (-0.71%)
CHRS : 19.33 (+2.28%)
LLY : 150.54 (-1.32%)
PFE : 38.01 (-0.83%)
TEVA : 11.61 (-0.26%)
Psoriasis Drug Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2020 - 2025

In its latest report on provides a concise analysis of the recent market trends. The report further includes statistics, market forecasts and revenue estimations, which in addition highlights its status...

AMGN : 240.01 (-0.71%)
BIIB : 288.18 (-1.72%)
CELGZ : 0.47 (+2.15%)
LLY : 150.54 (-1.32%)
GSK : 41.23 (-2.21%)
MRK : 83.14 (+0.56%)
NVS : 85.21 (+0.33%)
PFE : 38.01 (-0.83%)
TKPYY : 16.5900 (-0.90%)
VRX.TO : 30.80 (-3.33%)
Acute Otitis Media Treatment Market Analysis By Industry Size, Share, Revenue Growth, Development And Demand Forecast To 2029

The research study on Global Acute Otitis Media Treatment market 2019 presents an extensive analysis of current Acute Otitis Media Treatment market size, drivers, trends, opportunities, challenges, as...

ABT : 100.96 (+0.31%)
BAYRY : 16.9700 (-0.41%)
LLY : 150.54 (-1.32%)
GSK : 41.23 (-2.21%)
NVS : 85.21 (+0.33%)
PDP.VN : 0.300 (+1.69%)
Companies test antibody drugs to treat, prevent COVID-19

With a coronavirus vaccine still months off, companies are rushing to test what may be the next best thing: drugs that deliver antibodies to fight the virus right away, without having to train the immune...

REGN : 611.59 (-0.12%)
AMGN : 240.01 (-0.71%)
LLY : 150.54 (-1.32%)
VIR : 53.07 (+0.38%)
Large-Cap Pharma Industry Outlook Dull Amid Coronavirus Woes

Large-Cap Pharma Industry Outlook Dull Amid Coronavirus Woes

PFE : 38.01 (-0.83%)
NVS : 85.21 (+0.33%)
MRK : 83.14 (+0.56%)
LLY : 150.54 (-1.32%)
JNJ : 148.09 (-1.05%)
AZN : 55.74 (-1.76%)
ABBV : 94.92 (-0.62%)
Insulin Pens Market and COVID-19 Impact Assessment 2020-2030 Featuring Novo Nordisk, Eli Lilly & Co, Sanofi and Ypsomed - ResearchAndMarkets.com

The "Insulin Pens (Diabetes Care Devices) - Global Market Analysis and Forecast Model (COVID-19 market impact)" report has been added to ResearchAndMarkets.com's offering.

LLY : 150.54 (-1.32%)
NVO : 66.73 (-0.54%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Trade LLY with:

Business Summary

Eli Lilly and Company is a global healthcare leader that unites caring with discovery to make life better for people around the world. They were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and they remain true to that mission in all their...

See More

Key Turning Points

2nd Resistance Point 154.68
1st Resistance Point 153.61
Last Price 150.54
1st Support Level 151.04
2nd Support Level 149.54

See More

52-Week High 170.75
Last Price 150.54
Fibonacci 61.8% 144.24
Fibonacci 50% 136.05
Fibonacci 38.2% 127.87
52-Week Low 101.36

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar